Malignant melanoma (cancer of the skin or mucous membranes), developed at the expense of melanocytes (melanocytic tumor). (Photo by: CAVALLINI JAMES/BSIP/Universal Images Group via Getty Images)
BSIP/UNIVERSAL IMAGES GROUP VIA GETTY IMAGES
Nearly 70% of patients who received a mRNA vaccine in addition to immunotherapy were cancer free after five years from melanoma, compared to 49% of patients that just received immunotherapy, according to a new study published in the Journal of Clinical Oncology. Furthermore, 92% of patients who received the combination therapy were alive at five years, compared to just 71% who used immunotherapy alone.
Melanoma is a deadly skin cancer that is difficult to treat if not detected early, and it usually recurs in about half of patients that have been treated within the first five years.
How It Works?
